DeepSeek discourse misses why it's so great for software companies, says Canaccord's Kinglsey Crane
Kingsley Crane, Canaccord Genuity analyst, joins 'Money Movers' to discuss why the DeepSeek developments represent a ...
Vericel price target raised to $67 from $64 at Canaccord
Canaccord raised the firm’s price target on Vericel (VCEL) to $67 from $64 and keeps a Buy rating on the shares. The firm The firm updated its ...
Canaccord Genuity Keeps Their Buy Rating on Kingsgate Consolidated Limited (KSKGF)
In a report released on January 30, Tom Prendiville from Canaccord Genuity maintained a Buy rating on Kingsgate Consolidated Limited (KSKGF – ...
Canaccord Genuity lowers target price on Ultimate Products
Analysts at Canaccord Genuity lowered their target price on Ultimate Products from 182.0p to 130.0p on Monday, noting that ...
Stockhead on MSN5d
Broker Upgrades: Canaccord says disease specialist Opthea could triple if Phase III trial passes muster
Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial ...
Stockhead on MSN1h
Resources Top 5: Takeover whispers add lift to cashed-up goldie PDI
PDI locks in more than $69m from two strategic investors, heightening potential M&A activity of the Bankan gold project.
Spirit Blockchain Capital Inc. Announces LIFE Offering of Up to $3,000,000
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ...
Canaccord raises Vericel stock target to $67, maintains buy rating
Canaccord Genuity sustained its optimistic outlook on Vericel Corporation (NASDAQ:VCEL), raising the price target on the ...
Silver Storm Closes Additional Tranche of Its Non-Brokered Private Placement Offering Including Participation by First Majestic Silver Corp.
Silver Storm Mining Ltd. ("Silver Storm" or the "Company") (TSX.V: SVRS | FSE: SVR), is pleased to announce that on January 30, 2025, the Company closed an additional tranche ("Tranche") of the ...
GH Research Announces Proposed Public Offering
DUBLIN, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in ...
Agronomics (LON:ANIC) Earns Buy Rating from Canaccord Genuity Group
Agronomics (LON:ANIC – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Canaccord Genuity Group in a note issued to investors on Thursday, Marketbeat.com reports. They currently ...